US House Committee on Oversight and Government Reform held a Congressional Hearing on the state of prostate cancer diagnostics, which was requested and driven by AdMeTech in coordination with Rep. Elijah Cummings (D-MD). AdMeTech’s CEO Dr. Faina Shtern served as one of the expert witnesses. As the result of this hearing, Rep. Cummings re-introduced the $650…
[heading title_size=”title-size-small” text_align=”center” text_color_custom=”#ffffff” icon_type=”noicon” icon_size=”32″ icon_color=”#de5034″ icon_style=”circle” icon_color_bg=”#ffffff” icon_color_border=”#dbdbdb” icon_border_size=”1″ icon_border_radius=”500″ icon_border_spacing=”50″]PRIME Act[/heading] US House Committee on Oversight and Government Reform held a Congressional Hearing on the state of prostate cancer diagnostics, which was requested and driven by AdMeTech in coordination with Rep. Elijah Cummings (D-MD). AdMeTech’s CEO Dr. Faina Shtern served as one of…
US House Committee on Oversight and Government Reform held a Congressional Hearing on the state of prostate cancer diagnostics, which was requested and driven by AdMeTech in coordination with Rep. Elijah Cummings (D-MD). AdMeTech’s CEO Dr. Faina Shtern served as one of the expert witnesses. As the result of this hearing, Rep. Cummings re-introduced the $650…
HR 353 passed unanimously in the US House of Representatives, with strong bi-partisan support.
June 2007: The AdMeTech-driven prostate research Imaging & Men’s Health Education (Prime) Act (S. 1734) is introduced in US senate by Sen. Barbara Boxer (D-CA) to allocate $650 million over five years for research and education in diagnostics: $ 500 million for imaging technologies and 100 million for in vitro diagnostics. Co- Sponsors include senators John Kerry…